ECI Biotech

company

About

ECI Biotech is a premier developer and manufacturer of innovative, patented ExpressDetect a sensors for rapid infection.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$500K
Industries
Biotechnology,Health Care,Health Diagnostics,Manufacturing
Founded date
Jan 1, 1998
Number Of Employee
1 - 10
Operating Status
Active

ECI is developing and licensing its protein technologies for use in a wide range of industries with unmet needs, including nosocomial infections, medical diagnostics, industrial chemistry and consumer goods. ECI Biotech's product pipeline currently includes a diagnostic sensor for urinary tract infections, as well as advanced wound care systems designed to provide early warning of emergent infections and to promote healing. ECI presently also has 2 corporate partnerships with Fortune 100 companies in the medical device industry.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$500K
ECI Biotech has raised a total of $500K in funding over 2 rounds. Their latest funding was raised on Jan 26, 2010 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 26, 2010 Grant $500K 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
ECI Biotech is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant